Product
L19IL2 + L19TNF
1 clinical trial
1 indication
Indication
MelanomaClinical trial
A Pivotal Phase III, Open-label, Randomized, Controlled Multi-center Study of the Efficacy of L19IL2/L19TNF Neoadjuvant Intratumoral Treatment Followed by Surgery Versus Surgery Alone in Clinical Stage III B/C Melanoma PatientsStatus: Recruiting, Estimated PCD: 2024-10-01